Search

everythinglearnresearchcommunity

for

Search:↓

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Hair loss in black women needs more research, early intervention, and community education.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Damage to hair follicle stem cells may cause permanent hair loss and scarring in PCA.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

6.1% of patients seeking PRP for hair loss had undiagnosed cicatricial alopecia, which PRP cannot treat.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Hair transplants can be a treatment for scarring hair loss if there's good blood flow and no active disease.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Trichoscopy effectively diagnoses and monitors cicatricial alopecias, reducing the need for biopsies.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Horizontal sections of scalp biopsies are good for diagnosing Central Centrifugal Cicatricial Alopecia and help customize treatment.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.